Table A.56.2

Warning View the most recent version.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.

Archived

This page has been archived on the Web.


Table A.56.2
Total funds raised for bioproduct-related activities, by source and establishment size, 2015
Table summary
This table displays the results of Total funds raised for bioproduct-related activities. The information is grouped by Size (appearing as row headers), Funds raised, calculated using $ thousands units of measure (appearing as column headers).
Size Funds raised
$ thousands
Small (less than 50 employees)
Canadian based private venture capital 777Note E: Use with caution
American based private venture capital 0
Other private venture capital Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Financial Institutions (e.g., Chartered Banks, etc), cooperatives, credit unions Note x: suppressed to meet the confidentiality requirements of the Statistics Act
IPO (Initial Public Offering) or SPO (Secondary Public Offering) 0
Personal finance used towards this establishment 1,568Note E: Use with caution
Partner(s) from strategic alliance(s) Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Credit from suppliers 0
Angel investors, family or friends Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Government sources 4,271Note E: Use with caution
Other sources 2,098Note E: Use with caution
Medium (50 to 149 employees)
Canadian based private venture capital 0
American based private venture capital 0
Other private venture capital 0
Financial Institutions (e.g., Chartered Banks, etc), cooperatives, credit unions Note x: suppressed to meet the confidentiality requirements of the Statistics Act
IPO (Initial Public Offering) or SPO (Secondary Public Offering) 0
Personal finance used towards this establishment 0
Partner(s) from strategic alliance(s) Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Credit from suppliers Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Angel investors, family or friends 0
Government sources Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Other sources Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Large (more than 149 employees)
Canadian based private venture capital 0
American based private venture capital 0
Other private venture capital 0
Financial Institutions (e.g., Chartered Banks, etc), cooperatives, credit unions 0
IPO (Initial Public Offering) or SPO (Secondary Public Offering) 0
Personal finance used towards this establishment Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Partner(s) from strategic alliance(s) Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Credit from suppliers 0
Angel investors, family or friends 0
Government sources Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Other sources 0
x suppressed to meet the confidentiality requirements of the Statistics Act
E use with caution
Note:
Preliminary estimates, subject to change.
Due to rounding, components may not add to totals.
Coefficient of variation (CV) and standard error (SE) are used as quality indicators.
Source: Statistics Canada, Bioproducts production and development survey 2015.
Date modified: